HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Seiji Nishino Selected Research

Sleep Disorders

6/2008Armodafinil for excessive daytime sleepiness.
11/2007The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.
2/2007Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy.
1/2007Neuropeptides as possible targets in sleep disorders.
8/2006CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency?
11/2002Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders.
10/2002The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Seiji Nishino Research Topics

Disease

50Narcolepsy
12/2013 - 03/2002
29Cataplexy
11/2014 - 03/2002
13Disorders of Excessive Somnolence (Hypersomnia)
07/2010 - 10/2002
7Sleep Disorders
06/2008 - 10/2002
6Sleep Deprivation
11/2014 - 01/2004
5Nervous System Diseases (Neurological Disorders)
04/2011 - 10/2002
5Sleep Initiation and Maintenance Disorders (Insomnia)
11/2007 - 10/2002
3Demyelinating Diseases (Demyelinating Disease)
12/2009 - 05/2004
3Obstructive Sleep Apnea
02/2009 - 10/2002
3Idiopathic Hypersomnolence
02/2009 - 03/2002
2Encephalitis (Encephalitis, Rasmussen)
01/2014 - 01/2012
2Schizophrenia (Dementia Praecox)
01/2012 - 05/2002
2Neurodegenerative Diseases (Neurodegenerative Disease)
07/2010 - 12/2003
2Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
06/2003 - 10/2002
1Catatonia
01/2014
1Sleep Paralysis
09/2012
1Myotonic Dystrophy (Dystrophia Myotonica)
08/2012
1Teratoma (Teratoid Tumor)
01/2012
1Autistic Disorder (Autism)
12/2011
1Neuromyelitis Optica (Devic's Disease)
04/2011
1Alzheimer Disease (Alzheimer's Disease)
11/2009
1Cerebral Hemorrhage
01/2008
1Hemorrhage
01/2008
1Fatigue
11/2007
1Obesity
09/2006
1Body Weight (Weight, Body)
09/2006
1Ischemia
08/2006
1Inflammation
08/2006
1Heart Arrest (Cardiac Arrest)
08/2006
1Craniopharyngioma (Craniopharyngiomas)
11/2005
1Pain (Aches)
11/2005
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
08/2005
1Craniocerebral Trauma (Head Injury)
08/2005
1Infarction
08/2005
1Neoplasms (Cancer)
08/2005
1Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
11/2004
1Hyperphagia
01/2004
1Mood Disorders (Mood Disorder)
07/2003
1Niemann-Pick Diseases (Niemann Pick Disease)
06/2003
1Paralysis (Palsy)
12/2002

Drug/Important Bio-Agent (IBA)

51orexins (orexin)IBA
11/2014 - 03/2002
10modafinil (armodafinil)FDA Link
04/2012 - 07/2006
7Amphetamine (Amfetamine)FDA LinkGeneric
10/2011 - 06/2005
7Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
10/2011 - 06/2005
6Histamine (Histamine Dihydrochloride)FDA Link
12/2013 - 11/2002
5NeuropeptidesIBA
02/2007 - 11/2002
4Antidepressive Agents (Antidepressants)IBA
10/2011 - 07/2006
4Neurotransmitter Agents (Neurotransmitter)IBA
01/2010 - 11/2002
3AntigensIBA
12/2013 - 06/2002
3Acetylcholine (Acetylcholine Chloride)FDA Link
01/2010 - 01/2007
3Dopamine (Intropin)FDA LinkGeneric
11/2009 - 11/2002
3PeptidesIBA
11/2007 - 01/2007
3LeptinIBA
09/2006 - 01/2003
3human HLA-DQB1 proteinIBA
11/2005 - 10/2002
2N-Methylaspartate (NMDA)IBA
01/2014 - 01/2012
2Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
10/2011 - 06/2005
2AdenosineFDA LinkGeneric
07/2010 - 11/2002
2CytokinesIBA
02/2007 - 01/2007
2LipidsIBA
02/2007 - 01/2007
2Proteins (Proteins, Gene)IBA
02/2007 - 01/2007
2Hypnotics and Sedatives (Sedatives)IBA
02/2007 - 01/2007
2Amino AcidsFDA Link
02/2007 - 01/2007
2tranilast (N 5')IBA
08/2005 - 01/2003
1Hashimoto's encephalitisIBA
01/2014
1Doxycycline (Vibramycin)FDA LinkGeneric
12/2013
1Diphtheria ToxinIBA
12/2013
1Histidine DecarboxylaseIBA
12/2013
1RNA (Ribonucleic Acid)IBA
08/2012
1PhysostigmineIBA
06/2012
1AutoantibodiesIBA
01/2012
1L 644711 (B-3(+))IBA
01/2012
1Timothy syndromeIBA
12/2011
1L-Type Calcium Channels (Dihydropyridine Receptor)IBA
12/2011
1Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2011
1Serotonin (5 Hydroxytryptamine)IBA
10/2011
1AntibodiesIBA
04/2011
1Aquaporin 4IBA
04/2011
1Immunoglobulin G (IgG)IBA
04/2011
1HormonesIBA
01/2011
1venlafaxine (Effexor)FDA LinkGeneric
11/2010
11,7-dimethylxanthine (paraxanthine)IBA
07/2010
1Caffeine (No Doz)FDA LinkGeneric
07/2010
1Amyloid (Amyloid Fibrils)IBA
11/2009
1Desipramine (Pertofrane)FDA LinkGeneric
05/2009
1Dextroamphetamine (Dexedrine)FDA LinkGeneric
05/2009
1thioperamideIBA
01/2008
1zolpidem (Ambien)FDA LinkGeneric
11/2007
1Drug Receptors (Drug Receptor)IBA
11/2007
1Central Nervous System StimulantsIBA
01/2007
1C-Reactive ProteinIBA
08/2006
1Histamine H1 Receptors (Histamine H1 Receptor)IBA
11/2005
1N 30IBA
08/2005
1AutoreceptorsIBA
06/2004
1orexin receptorsIBA
06/2004
1SteroidsIBA
05/2004
1Biological Markers (Surrogate Marker)IBA
01/2003
1Deoxyglucose (2 Deoxy D glucose)IBA
12/2002

Therapy/Procedure

2Therapeutics
02/2007 - 01/2007
1Immunotherapy
03/2010
1Aftercare (After-Treatment)
05/2004